Study Evaluating the Addition of Amifostine (Ethyol®) to Idarubicin and Cytosine Arabinoside in Older Patients With Acute Myeloid Leukemia

Roswell Park Cancer Institute, Buffalo

Thomas Jefferson University Medical College, Philadelphia

Rambam Medical Center, Haifa

Baptist Clinical Research Center, Memphis

Cancer Care Center, New Albany

Henry Ford Health System, Detroit

Great Lakes Cancer Center Management Specialties, Grosse Point Woods

Cancer Management Specialists (No longer Recruiting), Grosse Pointe Woods

Rabin Medical Center, Petah Tikva

Spectrum Health Hospitals-Cook Research Dept. (No longer recruiting), Grand Rapids

Sheba Medical Center, Tel Hasomer

Medical College of Wisconsin, Milwaukee

Rush University Medical Center, Chicago

University of Kansas Medical Center, Kansas City

Kaplan Med. Center, Rehovot

Scripps Cancer Center, San Diego

St. Barnabas Health Care Center, Newark

Wake Forest University School of Medicine, Winston-Salem

Cleveland Clinic Foundation-Hemoatology/Oncology, Cleveland